Cite
Gabriely G, da Cunha AP, Rezende RM, et al. Targeting latency-associated peptide promotes antitumor immunity. Sci Immunol. 2017;2(11)doi: 10.1126/sciimmunol.aaj1738.
Gabriely, G., da Cunha, A. P., Rezende, R. M., Kenyon, B., Madi, A., Vandeventer, T., Skillin, N., Rubino, S., Garo, L., Mazzola, M. A., Kolypetri, P., Lanser, A. J., Moreira, T., Faria, A. M. C., Lassmann, H., Kuchroo, V., Murugaiyan, G., & Weiner, H. L. (2017). Targeting latency-associated peptide promotes antitumor immunity. Science immunology, 2(11), . https://doi.org/10.1126/sciimmunol.aaj1738
Gabriely, Galina, et al. "Targeting latency-associated peptide promotes antitumor immunity." Science immunology vol. 2,11 (2017). doi: https://doi.org/10.1126/sciimmunol.aaj1738
Gabriely G, da Cunha AP, Rezende RM, Kenyon B, Madi A, Vandeventer T, Skillin N, Rubino S, Garo L, Mazzola MA, Kolypetri P, Lanser AJ, Moreira T, Faria AMC, Lassmann H, Kuchroo V, Murugaiyan G, Weiner HL. Targeting latency-associated peptide promotes antitumor immunity. Sci Immunol. 2017 May 19;2(11). doi: 10.1126/sciimmunol.aaj1738. PMID: 28763794; PMCID: PMC5657397.
Copy
Download .nbib